Ibex Medical Analytics

Ibex’s CEO, Joseph (Yossi) Mossel, recently discussed the company’s mission to digitize #pathology and improve #cancerdiagnostics in a Q&A with Unite.AI. He noted, “Implementing responsible AI will help pathologists manage their workloads more effectively, improving diagnostic efficiency and reducing delays. By automating routine tasks, AI can lower error rates, improve the quality of diagnosis, and ultimately boost pathologists' confidence in their work.” Yossi also touched on the early challenges Ibex has overcome and the significance of their recent FDA 510(k) clearance, which opens exciting possibilities for the future of AI-powered #diagnostics. Check out his full Q&A here: https://lnkd.in/esZ2NkFk #AI #digitalpathology

We're just days away from #USCAP2025! Our team is excited to welcome everyone to Boston, our US headquarters. We have a packed schedule, don't miss the highlights below! We'll be at booth #929 offering live demos of the Ibex platform, the most widely deployed AI platform for cancer diagnostics and trusted by pathologists around the world. You view our robust clinical program and schedule your demo today: https://lnkd.in/eqrR9VE7 USCAP - United States and Canadian Academy of Pathology #pathology #USCAP #digitalpathology #cancerdiagnostics

Ibex’s CEO Joseph (Yossi) Mossel recently discussed our innovative technology for cancer diagnostics on The MedTech Impact Podcast! In an engaging conversation with hosts Kyle Kruse and Richard Meiklejohn, Yossi discussed how Ibex acts as a digital assistant to pathologists, the successful partnerships we've built in the industry, and how we're addressing workforce shortages while fostering trust through data and validation. Listen to his full episode here: https://lnkd.in/eThdd7QC

In this episode, hosts Kyle Kruse and Richard Meiklejohn, interview Joseph (Yossi) Mossel, CEO and Co-founder of Ibex Medical Analytics, about the company's innovative use of AI in cancer diagnostics. Yossi discusses the critical problem of diagnostic errors in pathology, which can reach up to 10% in some labs, and the growing shortage of pathologists worldwide. Ibex's AI technology acts as a "digital assistant" to pathologists, pre-analyzing cases and highlighting areas of concern, thereby increasing accuracy and efficiency. Yossi emphasizes that Ibex's AI is designed to augment, not replace, pathologists, allowing them to focus on complex cases while ensuring accuracy in routine diagnoses. The conversation touches on all the incredible data and partner foundations that been developed, which has led to significant deployments in Europe and the United States. Tune in to learn more about how Ibex is re-shaping pathology so you can be informed and inspired. https://lnkd.in/dsnGMcej #Pathology #CancerDiagnostics #AI #PathologyAssistant #Medtech #Community #KeepInnovating Katie Tarpey, Chaim Linhart, Judith Sandbank, MD, Yair Heller, Stuart Shand, Dalit Kahana-Garbi, Ellen Zhang, CFA, Michal Shoval, Michael Misialek, MD, Dr. Darshana Patil, Matthew Hiemenz, MD, MS, FCAP, Corinne Solier, Dr. Jaemin Park, Roya Khosravi-Far, Ph.D., PLD, Wafik S. El-Deiry, MD, PhD, FACP.

Our team had a wonderful day in Paris at the 1ère Journée IA et Pathologie, Société Française de Pathologie! Thank you to everyone who stopped by for a demo of the Ibex platform, the most widely deployed AI in pathology. We felt the strong enthusiasm for AI-powered pathology in France! Geraldine Sebag Emmanuelle Stebe Cees Smit #pathology #AI #digitalpathology #cancerdiagnostics

With the advancements in HER2-targeted therapies, it's more important than ever to have accurate and reproducible HER2 IHC scoring, particularly for lower levels of HER2 expression. This month at #USCAP2025, Dr. Elena Provenzano of Cambridge University Hospitals NHS Foundation Trust will present data showing the benefit of using Ibex's AI tools to differentiate between HER2 Ultra-low and HER2 Null breast cancers. Don't miss this session on Monday at 1pm during the Breast Pathology Platform! View Ibex's full clinical program and schedule your demo here: https://lnkd.in/gJd2KQuH USCAP - United States and Canadian Academy of Pathology #digitalpathology #cancerdiagnostics #breastcancer #pathology #precisionmedicine

Proud to be a woman in a leading organization with 50% women on our team! I’m inspired daily by a culture of equal opportunity and empowerment. Here’s to breaking barriers together! #WomenInBusiness #InternationalWomenDay2025 Ibex Medical Analytics

I am excited to announce that Heather Davis has joined Ibex Medical Analytics as our Vice President of Customer Operations. With over 20 years of experience in healthcare software, Heather brings expertise in professional services, customer support, and strategic growth. Heather is passionate about customer success and operational excellence and will support our customers as they transform cancer diagnosis and care through #AI-powered #digitalpathology workflows. Welcome to the team, Heather! 

Our CEO, Joseph (Yossi) Mossel, and VP of Clinical and Scientific Affairs, Manuela Vecsler, PhD, were both featured in Healthcare IT Today discussing the transformative role of AI in pathology. As Joseph shared, "When it comes to cancer, minutes matter. AI helps pathologists diagnose faster and more accurately, improving patient outcomes." Manuela added, "AI in clinical settings will revolutionize pathology, improving access to care, enhancing diagnostic precision, and ultimately saving lives." At Ibex, we’re proud to be at the forefront of AI-powered diagnostics, making a real impact on patient care and health equity. Read more: https://lnkd.in/efzy7qPG #AIinHealthcare #Pathology #CancerDiagnosis #HealthcareIT #Innovation

Join us at #USCAP2025 on Monday, March 24th at 12pm for a lunch symposium to learn from Mahul B. Amin M.D., Harsh Thaker, and Mariano de Socarraz on the role #AI is currently playing in the primary diagnosis of cancer. In this session, moderated by Manuela Vecsler, PhD, they'll share: 🔹 New data from robust precision and clinical validation studies as part of FDA clearance. 🔹Their digital pathology journeys and the benefits being seen after implementing AI-powered tools into routine clinical workflows (both private reference laboratories and academic medical centers). 🔹 Future outlook on AI's role in pathology and cancer diagnostics. View Ibex's full clinical program and schedule your demo here: https://lnkd.in/epBW5Xbx The University of Texas Medical Branch CorePlus Servicios Clínicos y Patológicos, LLC Labcorp University of Tennessee USCAP - United States and Canadian Academy of Pathology #digitalpathology #cancerdiagnostics #prostatecancer #pathology